Published in Nephrol Dial Transplant on May 01, 2007
Role of Regular Surveillance on Maintenance of Patency of an Arteriovenous Access | NCT04098159
Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 2.99
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
Cannulation technique influences arteriovenous fistula and graft survival. Kidney Int (2014) 1.41
Routine preoperative vascular ultrasound improves patency and use of arteriovenous fistulas for hemodialysis: a randomized trial. Clin J Am Soc Nephrol (2010) 1.13
Vascular access in haemodialysis: strengthening the Achilles' heel. Nat Rev Nephrol (2013) 1.09
Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc Dis (2014) 1.07
Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis. Clin J Am Soc Nephrol (2010) 1.06
Temporal risk profile for infectious and noninfectious complications of hemodialysis access. J Am Soc Nephrol (2013) 1.05
Re-envisioning Fistula First in a patient-centered culture. Clin J Am Soc Nephrol (2013) 1.03
Likelihood of starting dialysis after incident fistula creation. Clin J Am Soc Nephrol (2012) 0.94
Current tools for prediction of arteriovenous fistula outcomes. Clin Kidney J (2015) 0.94
Vein graft adaptation and fistula maturation in the arterial environment. J Surg Res (2014) 0.90
Novel paradigms for dialysis vascular access: upstream hemodynamics and vascular remodeling in dialysis access stenosis. Clin J Am Soc Nephrol (2013) 0.88
Improving incident fistula rates: a process of care issue. Am J Kidney Dis (2011) 0.88
Placement of hemodialysis catheters with a technical, functional, and anatomical viewpoint. Int J Nephrol (2012) 0.86
Practical aspects of arteriovenous fistula formation in the pediatric population. Pediatr Nephrol (2012) 0.86
Patient-specific computational modeling of upper extremity arteriovenous fistula creation: its feasibility to support clinical decision-making. PLoS One (2012) 0.86
Vascular access creation before hemodialysis initiation and use: a population-based cohort study. Clin J Am Soc Nephrol (2015) 0.85
Chronic kidney disease alters vascular smooth muscle cell phenotype. Front Biosci (Landmark Ed) (2015) 0.85
Should the arteriovenous fistula be created before starting dialysis?: a decision analytic approach. PLoS One (2011) 0.85
Color Doppler ultrasound and arteriovenous fistulas for hemodialysis. J Ultrasound (2014) 0.84
In search of an optimal bedside screening program for arteriovenous fistula stenosis. Clin J Am Soc Nephrol (2011) 0.83
Non-matured arteriovenous fistulae for haemodialysis: diagnosis, endovascular and surgical treatment. Bosn J Basic Med Sci (2010) 0.82
Arteriovenous Fistula Development in the First 6 Weeks after Creation. Radiology (2015) 0.82
The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death. J Am Soc Nephrol (2016) 0.82
Vein diameter after intraoperative dilatation with vessel probes as a predictor of success of hemodialysis arteriovenous fistulas. Med Sci Monit (2014) 0.81
Central vein stenosis in a dialysis patient: a case report. J Med Case Rep (2012) 0.81
The benefit of non contrast-enhanced magnetic resonance angiography for predicting vascular access surgery outcome: a computer model perspective. PLoS One (2013) 0.80
Preoperative assessment and planning of haemodialysis vascular access. Clin Kidney J (2015) 0.80
The Role of Shear Stress in Arteriovenous Fistula Maturation and Failure: A Systematic Review. PLoS One (2015) 0.79
Competing-risk analysis of death and dialysis initiation among elderly (≥80 years) newly referred to nephrologists: a French prospective study. BMC Nephrol (2013) 0.79
Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial. Nephrol Dial Transplant (2010) 0.79
Nitric Oxide Resistance Reduces Arteriovenous Fistula Maturation in Chronic Kidney Disease in Rats. PLoS One (2016) 0.79
Setting Priorities for Optimizing Vascular Access Decision Making--An International Survey of Patients and Clinicians. PLoS One (2015) 0.78
Survival of chronic hemodialysis patients over 80 years of age. Clin Interv Aging (2014) 0.78
Home haemodialysis and uraemic toxin removal: does a happy marriage exist? Nat Rev Nephrol (2012) 0.78
Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency. Diagn Interv Radiol (2015) 0.78
Overt intracardiac shunt flow after arteriovenous graft placement. Clin Exp Nephrol (2013) 0.77
Optimization of the convection volume in online post-dilution haemodiafiltration: practical and technical issues. Clin Kidney J (2015) 0.77
Frequent hemodialysis fistula infectious complications. Nephron Extra (2014) 0.76
Effect of ethnicity and socioeconomic status on vascular access provision and performance in an urban NHS hospital. Clin Kidney J (2016) 0.75
Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study. BMC Nephrol (2017) 0.75
Impact of preoperative ultrasonography findings on the patency rate of vascular access in Japanese hemodialysis patients. Springerplus (2016) 0.75
Complications of the Arteriovenous Fistula: A Systematic Review. J Am Soc Nephrol (2016) 0.75
Clinical outcome of percutaneous thrombectomy of dialysis access thrombosis by an interventional nephrologist. Kidney Res Clin Pract (2014) 0.75
Effect of intradialytic change in blood pressure and ultrafiltration volume on the variation in access flow measured by ultrasound dilution. Kidney Res Clin Pract (2012) 0.75
Percutaneous treatment of thrombosed hemodialysis arteriovenous fistulas: use of thromboaspiration and balloon angioplasty. Clujul Med (2017) 0.75
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP). NDT Plus (2009) 0.75
ACCESS HD pilot: A randomised feasibility trial Comparing Catheters with fistulas in Elderly patientS Starting haemodialysis. BMJ Open (2016) 0.75
Surgical interventions for late complications of arteriovenous fistulas. Int Surg (2014) 0.75
Vascular access and infection prevention and control: a national survey of routine practices in Irish haemodialysis units. Clin Kidney J (2013) 0.75
Determining when to measure vascular access flow …that may not be enough. Kidney Res Clin Pract (2013) 0.75
A dedicated vascular access clinic for children on haemodialysis: Two years' experience. Pediatr Nephrol (2016) 0.75
Long Term Outcomes of Arteriovenous Grafts for Hemodialysis in Lower Extremities. Vasc Specialist Int (2016) 0.75
Effect of online haemodialysis vascular access flow evaluation and pre-emptive intervention on the frequency of access thrombosis. NDT Plus (2008) 0.75
The impact of haemodialysis arteriovenous fistula on haemodynamic parameters of the cardiovascular system. Clin Kidney J (2016) 0.75
[Iatrogenic trauma of femoral artery secondary to the laying of hemodialysis catheter: about 4 cases]. Pan Afr Med J (2015) 0.75
Retroperitoneal approach for lower extremity arteriovenous graft as long-term vascular access in a complex case. Case Rep Nephrol Urol (2012) 0.75
Arteriovenous Access: Infection, Neuropathy, and Other Complications. Can J Kidney Health Dis (2016) 0.75
Arterio-Venous Fistula: Is it Critical for Prolonged Survival in the over 80's Starting Haemodialysis? PLoS One (2016) 0.75
Basilic Vein Transposition Used as a Tertiary Vascular Access for Hemodialysis: 15 Years of Experience. Open J Cardiovasc Surg (2016) 0.75
Bedside screening for fistula stenosis should be tailored to the site of the arteriovenous anastomosis. Clin J Am Soc Nephrol (2011) 0.75
Successful restoration of arteriovenous dialysis access patency after late intervention. Clin Kidney J (2014) 0.75
Dialysis: vascular access: not enough light at the end of the tunnel? Nat Rev Nephrol (2009) 0.75
Clinical use of computational modeling for surgical planning of arteriovenous fistula for hemodialysis. BMC Med Inform Decis Mak (2017) 0.75
Neuromuscular electrostimulation: a new therapeutic option to improve radio-cephalic arteriovenous fistula maturation in end-stage chronic kidney disease patients. Int Urol Nephrol (2017) 0.75
Predictors of nonfunctional arteriovenous access at hemodialysis initiation and timing of access creation: A registry-based study. PLoS One (2017) 0.75
The feasibility of surgical salvage of thrombosed arteriovenous fistula by an interventional nephrologist. Kidney Res Clin Pract (2017) 0.75
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med (2015) 18.66
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Acute renal failure. Lancet (2005) 5.60
Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2010) 5.50
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA (2012) 5.27
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant (2004) 4.27
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet (2003) 3.70
Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int (2003) 3.54
Performance liquid test as a cause for sudden deaths of dialysis patients: perfluorohydrocarbon, a previously unrecognized hazard for dialysis patients. Nephrol Dial Transplant (2002) 3.20
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol (2014) 3.06
Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int (2012) 3.02
Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med (2013) 2.96
The burden of kidney disease: improving global outcomes. Kidney Int (2004) 2.94
Management of crush-related injuries after disasters. N Engl J Med (2006) 2.90
Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol (2009) 2.89
Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol (2008) 2.76
EBPG guideline on nutrition. Nephrol Dial Transplant (2007) 2.68
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant (2010) 2.64
Acute kidney injury: an increasing global concern. Lancet (2013) 2.61
Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3. Mol Genet Metab (2008) 2.60
Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant (2012) 2.59
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51
Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 2.51
Acute kidney injury. Lancet (2008) 2.44
Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant (2012) 2.43
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J (2012) 2.42
The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant (2005) 2.38
Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant (2012) 2.27
Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant (2008) 2.24
Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation (2003) 2.22
Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol (2007) 2.18
Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant (2006) 2.17
Noninvasive assessment of local pulse pressure: importance of brachial-to-radial pressure amplification. Hypertension (2005) 2.15
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT). Mol Genet Metab (2010) 2.13
Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 2.10
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant (2003) 2.10
Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation (2009) 2.07
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant (2009) 2.06
The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol (2006) 2.01
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant (2012) 1.94
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int (2009) 1.93
Chronic kidney disease in adults--UK guidelines for identification, management and referral. Nephrol Dial Transplant (2006) 1.91
EBPG guideline on dialysis strategies. Nephrol Dial Transplant (2007) 1.90
Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2013) 1.90
Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol (2012) 1.90
Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant (2010) 1.90
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol (2008) 1.88
Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med (2006) 1.87
Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc (2007) 1.85
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr (2013) 1.85
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int (2004) 1.83
Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 1.83
Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant (2002) 1.81
Type I immune-mediated polyarthritis in dogs: 39 cases (1997-2002). J Am Vet Med Assoc (2004) 1.79
Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis (2007) 1.77
Physical activity and energy expenditure in haemodialysis patients: an international survey. Nephrol Dial Transplant (2011) 1.74
Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol (2002) 1.74
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J (2010) 1.72
Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Am J Cardiol (2006) 1.71
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet (2012) 1.69
Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients. Kidney Int (2013) 1.68
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet (2011) 1.68
Acute renal infarction: a case series. Clin J Am Soc Nephrol (2012) 1.68
The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol (2005) 1.67
EBPG guideline on haemodynamic instability. Nephrol Dial Transplant (2007) 1.65